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Abstract Resumen 
Context: Bacterial resistance to antibiotics is the inevitable consequence 
of the use of antimicrobial agents. Thus, quinolones are an important 
class of antibacterials; these agents generally consist of a 1-subtituted-
1,4-dihydro-4-oxopyridine-3-carboxylic acid moiety combined with an 
aromatic or heteroaromatic ring fused at the 5- and 6-position. 
Aims: To determine the binding of quinolones to DNA gyrase of 
Escherichia coli. 
Methods: An analysis was performed using an in silico approach to 
determine, by docking calculations and energy descriptors, the 
conformer of 4‐oxo‐1,4‐dihydroquinoline skeleton that forms the most 
stable complex with DNA gyrase of E. coli. 
Results: The complex shows that the pose of the quinolones coincides 
with the amino acid residues Asp87, Thr88, Arg91 and Met92, which is 
expected to be critical in the binding of quinolones to DNA gyrase of E. 
coli. A series of quinolones were computationally designed, and the 
interactions between the quinolones and the amino acid residues of the 
DNA gyrase were calculated. 
Conclusions: Among the designed compounds, compounds 105 and 115 
exhibit higher binding energy values and interact with amino acids 
Asp87, Thr88, Arg91 and Met92.  
Contexto: La resistencia bacteriana a los antibióticos es la consecuencia 
inevitable del uso de agentes antimicrobianos. Por lo tanto, las 
quinolonas son una clase importante de antibacterianos; estos agentes 
generalmente consisten en un resto ácido 1-sustituido-1,4-dihidro-4-
oxopiridina-3-carboxílico combinado con un anillo aromático o 
heteroaromático fusionado en las posiciones 5 y 6.  
Objetivos: Determinar la unión de quinolonas a ADN girasa de 
Escherichia coli. 
Métodos: Se realizó un análisis utilizando un enfoque in silico para 
determinar, mediante cálculos de unión y descriptores de energía, el 
confórmero del esqueleto de 4-oxo-1,4-dihidroquinolina que forma el 
complejo más estable con la ADN girasa de E. coli. 
Resultados: El complejo muestra que la postura de las quinolonas 
coincide con los residuos de aminoácidos Asp87, Thr88, Arg91 y Met92, 
que se espera que sean críticos en la unión de quinolonas a ADN girasa 
de E. coli. Se diseñó computacionalmente una serie de quinolonas, y se 
calcularon las interacciones entre las quinolonas y los residuos de 
aminoácidos de la ADN girasa. 
Conclusiones: Entre los compuestos diseñados, los compuestos 105 y 115 
exhiben valores de energía de unión más elevados e interactúan con los 
aminoácidos Asp87, Thr88, Arg91 y Met92.  
Keywords: Arguslab; DNA gyrase; docking; Escherichia coli; quinolones. Palabras Clave: acoplamiento molecular; ADN girasa; Arguslab; 
Escherichia coli; quinolonas. 
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INTRODUCTION 
Despite modern antibiotics, transmissible dis-
eases are responsible for nearly one third of hu-
man deaths worldwide. Bacterial resistance to an-
tibiotics is the inevitable consequence of the use of 
antimicrobial agents. Thus, quinolones are an im-
portant class of antibacterial; these agents general-
ly consist of a 1-subtituted-1,4-dihydro-4-oxo-
pyridine-3-carboxylic acid moiety combined with 
an aromatic or heteroaromatic ring fused at the 5- 
and 6-positions (Wube et al., 2012). 
Quinolones are highly effective antimicrobial 
drugs that target bacterial DNA gyrase and type II 
topoisomerase. Unfortunately, resistance to this 
class of drugs has become increasingly prevalent 
and is usually attributable to mutations in the 
DNA gyrase or a decrease in intracellular drug 
levels caused by changes in the membrane perme-
ability or the overexpression of drug efflux pumps 
(Chen et al., 2013). 
The level of drug resistance varies depending 
on the mutations and bacterial species. Quinolone 
inhibition of DNA gyrase occurs through the for-
mation of a stable ternary complex between DNA 
gyrase, DNA and the quinolone molecule that 
blocks the progression of DNA replications (Lu-
pala et al., 2013). 
The computational strategies for structure-
based drug discovery offer a valuable alternative 
to the costly and time-consuming process of ran-
dom screening  (Salgado-Moran et al., 2013). In 
this sense, docking calculations have been applied 
in pharmaceutical research for nearly two decades. 
Virtual screening on protein templates provides an 
opportunity for the identification of active com-
pounds (Perez et al., 2014). 
Considering these points, several quinolones 
with different substitutions were computationally 
designed. In this study, several quinolones as tar-
gets for antibiotics based on the molecular docking 
between new inhibitors and DNA gyrase using 
Arguslab were designed (Hafeez et al., 2013; 
Tangyuenyongwatana and Jongkon, 2016). 
In this study, antibiotic design was conducted 
with the modifications of hydrophilic and lipo-
philic characters of the molecules. The theoretical-
ly calculated binding affinities and binding posi-
tions of nalidixic acid, oxolinic acid, pipemidic ac-
id, ciprofloxacin, gatifloxacin, levofloxacin, lomef-
loxacin, moxifloxacin, rufloxacin, and sitafloxacin, 
which are commonly used antibiotics (Fig. 1) were 
compared with the new quinolones (supplemen-
tary data) (Lupala et al., 2013; Perez et al., 2014).  
 
Figure 1. 3D representation of DNA gyrase. 
MATERIAL AND METHODS 
The docking procedure is conceivable as a 
complicated optimization or an exhaustive search 
that involves many degrees of freedom. Hence, the 
development of efficient docking algorithms 
would be of vital importance for the design of new 
drugs (Zarate et al., 2016). The ultimate goal is to 
find the optimal ligand/protein configurations as 
well as to consistently predict their binding free 
energy without relying on formal statistical me-
chanics approaches. To computationally accom-
plish the key objective within a reasonable time 
framework, an empirical scoring function (AScore) 
and a docking engine (ShapeDock) were devel-
oped in the ArgusLab program (Oda and 
Takahashi, 2009). 
The AScore is based on the deconvolution of 
the total protein–ligand binding free energy into 
different components: 
∆G binding = ∆GvdW + ∆G hydrophobic + ∆G H-bond + 
∆G H-bond(chg) + ∆G deformation + ∆G°  
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The dissected terms account for the van der 
Waals interaction between the ligand and the pro-
tein (∆GvdW), the hydrophobic effect (∆G hydrophobic), 
the hydrogen bonding between the ligand and the 
protein (∆G hydrophobic), the hydrogen bonding that 
involves the charged donor and/or acceptor 
groups (∆G H-bond(chg)), the deformation effect (∆G 
deformation), and the effects of the translational and 
rotational entropy loss in the bidding process 
(∆G°).  
The ShapeDock engine approximates a compli-
cated search problem. Flexible ligand docking is 
available by describing the ligand as torsion tree. 
In this torsion tree approach, groups of bonded 
atoms that do not have rotatable bonds are nodes, 
while torsions are connections between the nodes. 
The topology of a torsion tree is a determinative 
factor that influences efficient docking. A balanced 
tree with a large central node is presumably the 
favorite case. Two grids overlay the binding site 
and distinguish grid points with respect to the free 
volume of the binding site. A fine grid is used to 
examine whether the atoms at an artificial position 
are inside or outside the binding site, while a 
coarse grid is used to establish the search points 
inside the binding site. A set of energetically fa-
vorable rotations is generated by placing the root 
node of a ligand on a search point in the binding 
site. The torsion search of the artificial positions is 
defined by constructing the torsions in a breadth-
first order for each rotation. Of the surviving arti-
ficial position candidates, the N-lowest energy 
poses make the final set of positions to undergo 
coarse minimization, re-clustering and ranking. 
The AScore/ShapeDock docking protocol is rapid 
and reproducible and formally explores all of the 
energy minima (Tangyuenyongwatana and Jong-
kon, 2016). 
Candidate optimized conformations of MP3  
semiempirical calculations (Hafeez et al., 2013) 
quinolones bound to their target structures, the 
DNA gyrase complex (Chen et al., 2013) . Proposed 
were using Arguslab. Here, docking was conduct-
ed with a set of 115 4-oxo-1,4-dihydroquinoline 
skeleton (see supplementary data). They were de-
fined to contain the potential binding pocket be-
tween Ala67 and Gln106 (Fig. 2). 
RESULTS AND DISCUSSION 
 
The docking results between the DNA gyrase 
receptor and designed 4‐oxo‐1,4‐dihydroquinoline 
skeleton are reported in Fig. 3. 
The standard antimicrobial agents nalidixic ac-
id, oxolinic acid, pipemidic acid, ciprofloxacin, gat-
ifloxacin, levofloxacin, lomefloxacin, moxifloxacin, 
rufloxacin, and sitafloxacin, on docking with DNA 
gyrase produce energy values of -7.9880, -6.9640, -
7.7810, -6.4840, -7.5950, -7.2860, -7.7860, -7.2980, -
7.1710 and -8.1440 Kcal/mol, respectively. 
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Figure 2. Structures of the quinolones used in the docking calculations. 
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To recognize the hypothetical binding mode 
and interaction of quinolones with crucial amino 
acid residues in the DNA gyrase complex, a mo-
lecular docking study was conducted using the 
crystal structure of DNA gyrase. The percentage 
frequency of the interaction of quinolones with 
different amino acids (a maximum distance is 20 
Å) is as follows: 20% Ala67, 10% Lys76, 20% Tyr77, 
30% His78, 10% Pro79, 30% His80, 20% Gly81, 40% 
Asp82, 50% Ser83, 50% Ala84, 40% Val85, 30% 
Tyr86, 100% Asp87, 80% Thr88, 60% Ile89, 70% 
Val90, 80% Arg91, 70% Met92, 50% Ser97, 50% 
Leu98, 20% Arg99, 20% Met101, and 60% Leu102. 
For the most stable conformer of the quinolones 
(Fig. 4), its crucial amino acid residues (Asp87, 
Thr88, Arg91 and Met92) are at the following dis-
tances (from the Cα of the amino acid to the C1 of 
the quinolones): 8.068 Å, 9.7170 Å, 8.5810 Å and 
7.4230 Å, respectively, for nalidixic acid; 10.0358 Å, 
6.9688 Å, 5.9936 Å and 4.7015 Å, respectively, for 
oxolinic acid; 10.6030 Å, 7.8760 Å, 6.9830 Å and 
6.7880 Å, respectively, for pipemidic acid; 11.3730 
Å, 8.2780 Å, 7.990 and 7.1580 Å, respectively, for 
ciprofloxacin; 8.2100 Å, 6.5070 Å, 10.9330 Å and 
11.9860 Å, respectively, for gatifloxacin; 7.1750 Å, 
5.3080 Å, 6.8080 Å and 8.4380 Å, respectively, for 
levofloxacin; and 11.6980 Å, 8.2490 Å, 7.9380 Å 
and 5.5570 Å, respectively, for rufloxacin. 
DNA gyrase is a target of quinolone. However, 
the molecular details of the quinolone-gyrase in-
teraction are not clear. Quinolone resistance muta-
tions frequently occur at the residues Ser83 and 
Asp87 of the GyrA subunit; thus, it is possible that 
these residues are involved in drug binding. 
Moreover, Asp87 might be critical in the binding 
of fluoroquinolones (Wu et al., 2013). 
Efforts to develop novel bacterial topoisomer-
ase inhibitors that aim to overcome quinolone re-
sistance have led to the identification of new bind-
ing sites, which suggests that in addition to the 
cleavage site-specific targeting strategy, alternative 
drug binding modes for promoting cell death 
should also be explored (Banoth et al., 2017). 
These results allow us to explain the experi-
mental results because Asp87 is the amino acid 
that has the highest frequency of interaction with 
the quinolones and has been found to be critical in 
the binding of these drugs (see Fig. 3).  
 
Figure 3. Graphic linking energy, distances from the Cα of 
the amino acid to the C1 of the quinolones and the 
percentage frequency of interaction of the quinolones with 
different amino acids. 
Interactions between the quinolones and select-
ed amino acids were observed; this interaction is 
achieved by high affinity groups forming hydro-
gen bonds on the carboxyl group (C=O) and amine 
group (NH2) of the amino acids [S1] which, in the-
ory, could possess an inhibitory action on the en-
zyme E. coli gyrase. Of the new 115 quinolone 
structures (see supplementary data) that have been 
evaluated, considering the energy criteria, distance 
and type of amino acid, there were two new struc-
tures that could present an inhibitory action on the 
gyrase enzyme. These structures are numbers 105 
and 115, which had an energy interaction of -
4.1122 and -5.4234, respectively; furthermore, they 
showed an interaction with the amino acids 
Asp87, Thr88, Arg91 and Met92 with distances of 
10.7745 Å, 7.4566 Å, 7.0545 Å and 5.3309 Å, respec-
tively, for structure 105, and 10.7618, 7.5107, 
6.8671, and 5.1444, respectively, for structure 115. 
These new compounds could be potential antibac-
terial quinolones. 
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Figure 4. Structure and the distances from the Cα of the amino acid to the C1 of the quinolones. 
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CONCLUSIONS 
DNA gyrase, which is an essential target for 
novel drug design, was docked with the standard 
antimicrobial agents nalidixic acid, oxolinic acid, 
pipemidic acid, ciprofloxacin, gatifloxacin, 
levofloxacin, lomefloxacin, moxifloxacin, rufloxa-
cin, and sitafloxacin. When the designed quino-
lone analogs were docked against the DNA gyrase, 
the results indicate that the 105 and 115 com-
pounds can be potent antibacterial agents. Analy-
sis of the binding models suggests that the amino 
acid residues Asp87, Thr88, Arg91 and Met92 are 
critical in the binding of quinolones to the DNA 
gyrase of E. coli. 
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